Marsh & McLennan Companies, Inc. reports results for the quarter ended September 30 — Earnings Summary
Marsh & McLennan Companies, Inc. reported quarterly adjusted earnings of $2.03 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.85. The mean expectation of twenty four analysts for the quarter was for earnings of $1.97 per share. Wall Street expected results to range from $1.92 to $2.01 per share. Revenue rose 8.1% to $6.86 billion from a year ago; analysts expected $6.64 billion. Marsh & McLennan Companies, Inc.'s reported EPS for the quarter was $1.69. The company reported quarterly net income of $808 million. Marsh & McLennan Companies, Inc. shares had risen by 4.5% this quarter and lost 3.8% so far this year. Forecast Changes The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. In the last 30 days, eight analysts negatively revised earnings estimates Recommendations The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy," 17 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the multiline insurance & brokers peer group is also "hold" Wall Street's median 12-month price tar
Marsh & McLennan Companies, Inc. reported quarterly adjusted earnings of $2.03 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.85. The mean expectation of twenty four analysts for the quarter was for earnings of $1.97 per share. Wall Street expected results to range from $1.92 to $2.01 per share.
Revenue rose 8.1% to $6.86 billion from a year ago; analysts expected $6.64 billion. Marsh & McLennan Companies, Inc.'s reported EPS for the quarter was $1.69. The company reported quarterly net income of $808 million. Marsh & McLennan Companies, Inc.
shares had risen by 4.5% this quarter and lost 3.8% so far this year. Forecast Changes The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. In the last 30 days, eight analysts negatively revised earnings estimates Recommendations The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy," 17 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the multiline insurance & brokers peer group is also "hold" Wall Street's median 12-month price target for Marsh & McLennan Companies, Inc.
is $196.16, about 9.1% above its last closing price of $178.40 This summary was machine generated from LSEG data October 15 at 01:33 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com.
For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED Sep. 30 2026 1.97 2.03 Beat Jun. 30 2026 2.90 2.96 Beat Mar. 31 2026 3.23 3.29 Beat Dec.
31 2025 1.97 2.12 Beat